The former Rhode Island anesthesiologist who spent more than 20 years on the run to avoid being prosecuted on sexual assault charges may have been living a double life as a biotech executive, 12 ...

Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...

Valdosta State University has announced the members of its graduating class of Spring 2026, including the following list of area residents. Area graduates include:  Helen Allen of Adel […] ...

ACTiVION-II, the first of two US Phase 3 clinical trials, did not meet co-primary endpoints of VAS pain score and WOMAC total score at Month 12Results from ACTiVION-I, the second Phase 3 trial of TG-C ...

Here's a look at some local developments that underscore the opportunities and challenges that lie ahead for Massachusetts.

Billionaire Steve Cohen still backs biotech Evommune despite trial setbacks, highlighting its potential for treating chronic ...

Pakistan achieved another milestone in international science competitions as the national team secured a Silver Medal and a ...

Investors are increasingly drawn to Scottish companies in sectors that speak to a broader strategic confidence in what ...

CSL shares have staged a powerful rebound, but after losing half their value over the past year, can the recovery continue, ...

After four years of preparation, Vishal Tiwari from Gorakhpur has cleared NEET UG 2026 with 605 marks. The 23-year-old, who got married shortly after finishing school and later became a father, ...

BBH offers concentrated exposure to biotech, while IHE provides higher income with lower volatility by focusing on established drugmakers.

That pathway is adjacent to the one that the GLP-1 medicines use, so it could technically be targeted by a combination ...